drugset / Trial / NCT02259959
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics of BI 1744 CL and Tiotropium Bromide when given as fixed dose combination
Timeline
- Start
- 2007-04
- Primary completion
- 2007-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olodaterol | Small molecule | 2 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 10 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 40 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 5 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 10 ug | Inhaled |
Indications
No indication recorded.